Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-10-02 | Christopher B. Begley (Chair) Founder and former Chairman and CEO, Hospira, Inc. (Retired) Age: 63 Director since 2011 Committees: Compensation, Nominating & Governance 2015 Director Compensation: $260,835 |
| 2016-10-04 | Mr. Begley has been a director of DeVry Group since November 2011 and Chair of the DeVry Group Board of Directors since November 2014. Committees: Compensation, Nominating & Governance (Chair). In fiscal year 2016, non-employee directors, other than the Board Chair, received an annual retainer of $70,000, paid quarterly. The Board Chair received an annual retainer of $120,000. Total compensation for Mr. Begley was $291,801. |
| 2017-05-01 | Non-Employee Directors Christopher B. Begley Non-Employee Director |
| 2017-10-04 | Christopher B. Begley (Chair) Founder and former Chairman and CEO, Hospira, Inc. (Retired) Age: 65 Director since 2011 Committees: none 2017 Director Compensation: $296,350 |
| Filing Date | Source Excerpt |
|---|---|
| 2017-03-30 | Executive Chairman of the Board of Hospira, Inc. from May 2007 until his retirement in January 2012. Mr. Begley also served as Chief Executive Officer from April 30, 2004, when Hospira was spun off from Abbott Laboratories, to March 2011. Prior to that, Mr. Begley served in various positions with Abbott between 1986 and 2004, most recently as Senior Vice President of Abbott’s Hospital Products division. |
| 2018-04-02 | Christopher B. Begley’s past experience as the Chairman and CEO of Hospira, Inc., a leading provider of injectable drugs and infusion technologies, and previously as the senior vice president of two Abbott divisions, has provided him with extensive management experience at two multinational, publicly traded healthcare companies. |
| 2019-03-27 | Christopher B. Begley’s past experience as the Chairman and CEO of Hospira, Inc., a leading provider of injectable drugs and infusion technologies, and previously as the senior vice president of two Abbott divisions, has provided him with extensive management experience at two multinational, publicly traded healthcare companies. |
| 2020-03-25 | Christopher B. Begley’s past experience as the Chairman and CEO of Hospira, Inc., a leading provider of injectable drugs and infusion technologies, and previously as the senior vice president of two Abbott divisions, has provided him with extensive management experience at two multinational, publicly traded healthcare companies. |
| 2021-03-31 | Christopher B. Begley’s past experience as the Chairman and CEO of Hospira, Inc., a leading provider of injectable drugs and infusion technologies, and previously as the senior vice president of two Abbott divisions, has provided him with extensive management experience at two multinational, publicly traded healthcare companies. |
| 2022-03-29 | He earned a bachelors degree from Western Illinois University and an MBA from Northern Illinois University. No mention of computer science or programming experience. |
| 2023-03-30 | Christopher B. Begley’s past experience as the Chairman and CEO of Hospira, Inc., a leading provider of injectable drugs and infusion technologies, and previously as the senior vice president of two Abbott divisions, has provided him with extensive management experience at two multinational, publicly traded healthcare companies. |
| 2024-03-27 | Christopher B. Begley’s past experience as the Chairman and CEO of Hospira, Inc., a leading provider of injectable drugs and infusion technologies, and previously as the senior vice president of two Abbott divisions, has provided him with extensive management experience at two multinational, publicly traded healthcare companies. |
Data sourced from SEC filings. Last updated: 2026-02-03